Jaguar Health (JAGX) Interest Coverage Ratio (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Interest Coverage Ratio of 5.9 for Q1 2026, up 134.23% year-over-year from 2.52 in Q1 2025, and up 109.35% quarter-over-quarter from 63.03 in Q4 2025.
Jaguar Health (JAGX) Interest Coverage Ratio (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Interest Coverage Ratio for 13 consecutive years, with 5.9 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 134.23% year-over-year to 5.9; the TTM figure through Mar 2026 stood at 15.23 (up 73.99% YoY), while the FY2025 annual figure was 25.18, down 7542.52% from the prior year.
- Interest Coverage Ratio climbed to 5.9 in Q1 2026 per JAGX's latest filing, from 63.03 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 5.9 in Q1 2026 and bottomed at 74.15 in Q4 2024.
- Historically, Interest Coverage Ratio has averaged 13.83 across 5 years, with a median of 3.9 in 2024.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio surged 147.28% — and 2023, when it plunged 1293.67%.
- Jaguar Health's Interest Coverage Ratio stood at 4.49 in 2022, then slumped by 1293.67% to 53.6 in 2023, then sank by 38.36% to 74.15 in 2024, then gained by 15.0% to 63.03 in 2025, then surged by 109.35% to 5.9 in 2026.
- Business Quant data shows JAGX's Interest Coverage Ratio at 5.9 in Q1 2026, 63.03 in Q4 2025, and 3.97 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | Jaguar Health | 452,552.38 | -9.61 Mn | 19.11 Mn | 14.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.90 |
| Dec 31, 2025 | -63.03 |
| Sep 30, 2025 | -3.97 |
| Jun 30, 2025 | -3.84 |
| Mar 31, 2025 | -17.22 |
| Dec 31, 2024 | -74.15 |
| Sep 30, 2024 | -4.04 |
| Jun 30, 2024 | -3.90 |
| Mar 31, 2024 | -1.48 |
| Dec 31, 2023 | -53.60 |
| Sep 30, 2023 | -4.50 |
| Jun 30, 2023 | -2.35 |
| Mar 31, 2023 | -4.51 |
| Dec 31, 2022 | 4.49 |
| Sep 30, 2022 | -3.62 |
| Jun 30, 2022 | -2.55 |
| Mar 31, 2022 | -2.80 |
| Dec 31, 2021 | 1.82 |
| Sep 30, 2021 | -4.59 |
| Jun 30, 2021 | -5.76 |